Consultant in Polymers and Process scale up
Dr. Steve Daren
CEO and Founder of Daren Labs
Dr. Daren is a renowned and respected consultant in many fields such as plastics, polymers, adhesives and flame-retardants. For more than thirty years, Dr. Daren has been providing solutions to literally hundreds of problems related to the chemical, pharmaceutical, polymer and plastic industries. Dr. Steve Daren has provided numerous expert opinions to Israeli and over-seas governmental authorities and courts of law. Steve has been a project examiner in the European community (EU). Steve is also a recipient of several European Grants from the FP6 to the Horizon 2020 frameworks.
A graduate of the University of London and the Weizmann Institute of Science, Steve is the inventor of many patents in the fields of agriculture, battery-electrolytes, plastics, flame-retardants, cosmetics and more.
Consultant in Surface Technology and Chemistry
Dr. Elliott R. Silcoff
R&D Manager, Daren Labs
Dr. Silcoff has vast experience in a broad array of chemistries. He has led research with top companies worldwide and in Israel and, was the founder of several new ventures.
Dr Elliot Silcoff provides expert’s opinion to governmental authorities and courts of law in Israel. Elliott is an expert in the fields of synthetic organic and organometallic chemistries, surfactants, electrochemistry, and surface technologies, in addition to being very adept at valorization and commercialization of new materials and processes.
Elliot is a graduate of the Hebrew University and a former faculty member at Stanford University. He is the author of several scientific articles and over 30 patents.
Dr. Fabienne Lellouche
Project Leader, Daren Labs
Dr. Lellouche has more than 30 years’ experience of managing interdisciplinary projects such as microorganism entrapment, medical devices, cosmetic formulations, supramolecular and Nano-chemistry. In parallel to project supervision, Fabienne daily assists start-ups in the Daren Innovation Center on their analytical research and overseas business development.
In Europe, Dr Lellouche has led major Agritech and Foodtech projects from concept to final product. At the CEA Atomic Energy Research Center, France, Fabienne developed new methods for the recovery of radioactive waste.
Fabienne earned her MBA from the ESDES, her PhD from UCB-Lyon 1, France, and completed her Post doctorate at Tel-Aviv University.
Consultant in Protein Purification
Dr. Mario Lebendiker
Head, Protein Purification Facility, Wolfson Centre for Applied Structural Biology, HUJI
In charge of theoretical and practical courses in protein function. Dr. Lebendiker is actively involved in many collaborations in structural and biochemical studies with universities in Israel, as well as with biotech and pharmaceutical companies. Together with many other laboratories, he founded in 2010 the Protein Production and Purification Partnership in Europe (P4EU) network; a platform for the exchange of information, know-how and materials between core facility labs in the field of protein expression and purification, that meets twice a year (https://p4eu.org). Dr. Mario Lebendiker was the group leader of the protein department of Sigma Chemicals for 10 years and was in charge of project research development and production of more than 100 fine natural biochemical products that became an integral part of the Sigma catalogue (lectins, affinity resins, bacterial protein toxins, proteoglycans, enzymes, etc.). Mario is the co-author of more than 50 publications in international journals. Mario received his PhD in Biochemistry in 1982 in Buenos Aires University, Argentina.
Consultant in Biotechnology
Dr. Shmulik Ittah
Dr. Ittah is an Israeli scientist and a Biotech expert, with a proven track record in global life sciences and developing innovative products and services. With his more than 20 years of extensive and diverse experience in biotechnology research and working with related companies, he has extensive knowledge of medical devices, protein expression, computational biology and the global biotech startup landscape.
In 2014, Dr. Ittah co-founded Seevix Material Sciences LTD, in order to produce and commercialize man-made spider silk, the Holy Grail in the silk fiber industry. His silk fibers were introduced in various industrial fields, including the launch of the first spider silk based product in the world.
As an entrepreneur at heart, he co-founded Pepticom LTD and served as its CEO. Dr. Ittah is the author of numerous papers in the field of spider silk proteins, which were published in peer-reviewed journals and holds several patents in the field of spider silk. Dr. Ittah holds a Ph.D. in Biology from the Hebrew University and conducted a Post-Doc at Novartis Ltd.
Consultant in Medical Devices
I.C.S CEO, RA & QA specialist
Internationally certified lead auditor for medical devices companies per ISO 13485 and per FDA, Nissim Shaked held key positions in companies developing innovative medical devices and systems. Nissim is involved in Medical devices design, production, quality assurance and regulatory affairs.
Since 1994, Nissim has specialized in assisting start-ups from early stage Research and Development, as well as mature companies by establishing and upgrading quality management systems.
Nissim has hands-on experience in leading regulatory and quality systems for Europe (EU) and USA (FDA) in product design, transfer and production.
Nissim is also an expert in clean rooms, and implant sterilization processes.
Consultant in Immunology
Dr. Riva Kovjazin, M.D.
Dr. Riva Kovjazin is an expert in the field of immunology with over 25 years of experience in cellular immunology. From 1997, Dr Riva Kovjazin held various positions at XTL Biopharmaceuticals and at VaxilBio.
In addition, Riva was a project leader at the Center for clinical immunology, University of Medicine, Moscow, Russia where she studied the clinical immunology and diagnosis aspects of HIV. Riva obtained her degree in medicine from the School of Medicine of the University of Perm and specialized in the advanced study of immunology and epidemiology of conventional infectious diseases at the Rostov Research Institute, Russia.
In Daren Labs, Riva is assisting start-ups to tackle flow cytometry and fluorescence-activated cell sorting (FACS) analyses.
Consultant in Synthetic Biology
Dr. Ofer Nussbaum
Dr. Ofer Nussbaum is a graduate of the Hebrew University of Jerusalem. As a biochemist, specializing in molecular biology and genetic healing at the NIH, Dr. Nussbaum has more than 30 years of experience in research and development. He has authored many articles and several patents, and has experience in managing research groups and biotechnology companies in his areas of expertise.
In the field of diagnostics, he has developed methods and systems for identifying biological markers by immunological methods and molecular biology and diverse methods in the quantification and evaluation of nucleic acids and the use of nucleic acid epitheliums.
In the field of pharma: development of methods and systems in medicinal chemistry and chemical synthesis, development of drugs based on various molecules and nanoparticles, including and use of nucleic acid aptamers for cellular therapy, genetic therapy, and immunotherapy.
In addition, Dr. Nussbaum has experience in performing IP assessment, market and product analysis, and building development and business plans.